AtHome Pediatric Care Devices Could Address Access Gap for Millions of Children
Signos Secures 20M in Funding to Expand AIPowered Glucose Monitoring for Weight Loss
Polymarket Traders Bet SpaceX OpenAI Could Surpass Berkshire Hathaway on First Trading Day
TikToks Monetization Model How Creators and Businesses Generate Sustainable Income
Indian Rupee Rebounds Past 96 on Strong RBI Intervention
SpaceX IPO Speculation Nvidia Earnings Focus and Bezos AI Bubble Comments Lead Market Watch
Standex International SXI Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher
LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction
VSAT Q1 2026 Earnings Stellar EPS Beat Drives Positive Market Reaction
EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower
MSFT Q1 2026 Earnings EPS Beat Highlights Resilient Cloud and AI Momentum
ITT Inc Q1 2026 Earnings Strong Profit Beat Despite Mixed Demand Signals
BioVie Inc BIVI Faces Selling Pressure as Shares Slide 59
Xsolla SPAC 1 XSLL Holds Steady at 990 as Market Awaits Catalysts
Foremost Clean Energy FMST Advances 124 as Clean Energy Sector Finds Footing
Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels
Exelon EXC Slides Slightly as Utility Sector Faces Mixed Sentiment
Indian Equity Markets Wobble Hind Zinc SBI Force Motors Drive Activity Amid Mixed Sector Performance
ALMS Q1 2026 Earnings NarrowerthanExpected Loss and Pipeline Progress
Fifth Era Acquisition Corp I FERA Holds Steady at 1038 as SPAC Market Awaits Catalyst
QS Q1 2026 Earnings Narrower Loss Surprises But Stock Falls 215 Amid Continued PreRevenue Phase
General Mills Q1 2026 Earnings EPS Misses Estimates by Nearly 13 as Stock Edges Higher
PAY Q1 2026 Earnings EPS Surpasses Estimates by Nearly 21
DUOT Q1 2026 Earnings WiderThanExpected Loss But Shares Surge
GNS Q4 2022 Earnings Massive EPS Miss as Reported Loss Exceeds Estimates by Wide Margin
Forrester Research Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions
ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss